U.S. markets close in 4 hours 41 minutes

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
7.12-0.34 (-4.56%)
As of 11:12AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close7.46
Bid7.13 x 900
Ask7.19 x 800
Day's Range7.11 - 7.50
52 Week Range6.45 - 28.20
Avg. Volume265,728
Market Cap415.564M
Beta (5Y Monthly)-0.25
PE Ratio (TTM)N/A
EPS (TTM)-5.40
Earnings DateNov 01, 2023 - Nov 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.09
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for IGMS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IGM Biosciences, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/05/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • Zacks

    Orchard Therapeutics PLC Sponsored ADR (ORTX) Soars 12.9%: Is Further Upside Left in the Stock?

    Orchard Therapeutics PLC Sponsored ADR (ORTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  • GlobeNewswire

    IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

    MOUNTAIN VIEW, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023, at 9:30 a.m. EDT. A live audio webcast of the event will be available on the “Events and Presentations” page

  • TipRanks

    Down More Than 50%: These 2 ‘Strong Buy’ Stocks Are Too Cheap to Ignore

    Who doesn’t love a bargain? Buying quality for a low price is one of the thrills of the market system – and that applies to stock markets as well. The trick is knowing which rock-bottom stocks are the right ones to buy. Plenty of stocks are priced low, and bargain-hunting investors need to find the ones whose fundamentals are sound. The sheer volume of stocks, and the reams of data they produce, makes that difficult – but Wall Street analysts make their living by taking deep dives behind the sce